Clinical Trials
2 trialsNCT01838317 2021-03-01
A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT00867126 2018-11-26
Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated